ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Vertex Pharmaceuticals Incorporated

Official 2024 U.S. DOL Form 5500 summary for Vertex Pharmaceuticals Incorporated (Vertex Pharmaceuticals Incorporated 401(k) Plan · EIN 04-3039129 · PN 001): $1.31B net assets, 5,091 active participants, and $0.48 per $10,000 (0.48 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorVertex Pharmaceuticals Incorporated
Filing IdentifierVertex Pharmaceuticals Incorporated 401(k) Plan · EIN 04-3039129 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort>$1B
Plan Net Assets (2024)$1.31B
Active Participants5,091
Direct Admin Fee Rate$0.48 per $10,000 (0.48 bps)
Cohort Peer Median$4.40 per $10,000 (4.40 bps)
Primary Recordkeeper / ProviderCAPTRUST
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI

Cross-Agency Entity Graph

Related Filings Across Meru Platforms

Verified federal filings reconciled for Vertex Pharmaceuticals across sibling Meru AI platforms.